C9orf102 Inhibitors

Inhibitors of C9orf102 target the intricate network of DNA repair and damage response pathways in which this protein is involved. By impeding the function of proteins such as poly(ADP-ribose) polymerases, critical facilitators of the DNA repair machinery are compromised, leading to an indirect inhibition of C9orf102's activity in these pathways. Additionally, the functional integrity of C9orf102 is challenged by compounds that target other key players in the DNA repair process, such as the Mre11 complex, DNA-PK, ATM kinase, and ATR kinase. The collective impairment of these proteins cascades down to C9orf102, hindering its ability to participate effectively in the DNA repair and replication processes. This orchestrated disruption not only affects the immediate repair mechanisms but also extends to compromise the cell's ability to manage DNA damage, consequently diminishing the functional presence of C9orf102 in these essential cellular activities.

Moreover, the inhibition of checkpoint kinases like WEE1 and CHK1 further destabilizes the cellular frameworks that safeguard against genomic instability, where C9orf102 plays a key role. The targeted weakening of these kinases results in the abrogation of critical DNA damage checkpoints, which indirectly impacts the capacity of C9orf102 to maintain genomic fidelity during DNA replication and repair. In a similar vein, the inhibition of phosphoinositide 3-kinases disrupts vital cell survival signals, contributing to the reduced functionality of C9orf102 within its DNA repair context.